Delivery Order SPE2DB22D2206-SPE2DB24FFN64
Award Date
2/8/24
Potential Completion Date
2/9/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $12,430.41, is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a completion date of May 2, 2023. The contract is a Delivery Order and is priced as a Firm Fixed Price. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of OPZELURA 1.5% cream in 60-gram quantities. The contract, valued at $10,114.83, is a delivery order with a firm fixed price and an ultimate completion date of May 7, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $2,794.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a period of performance through December 29, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $15,092.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product OPZELURA 1.5% CREAM 60GM. The contract has an ultimate completion date of December 28, 2023 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide OPZELURA 1.5% Cream 60GM to the government. The contract has a ceiling value of $2,503.47 and is a firm-fixed price delivery order that expires on December 29, 2023. The contract was awarded on December 28, 2022, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,301.20 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram tubes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of OPZELURA 1.5% CREAM 60GM pharmaceutical products. The $3,737.85 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense, with an ultimate completion date of March 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $2,347.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, with a completion date of July 21, 2023. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is a for-profit organization registered in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,676.59 firm-fixed-price delivery order contract is for the supply of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 2, 2025 and was awarded on December 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,623.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a 60-gram pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...